These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 16231858)
1. Lost in translation. Nat Rev Microbiol; 2005 Oct; 3(10):742. PubMed ID: 16231858 [No Abstract] [Full Text] [Related]
2. Profitable gifts: a history of the Merck Mectizan donation program and its implications for international health. Collins K Perspect Biol Med; 2004; 47(1):100-9. PubMed ID: 15061171 [TBL] [Abstract][Full Text] [Related]
3. The life and times of ivermectin - a success story. Omura S; Crump A Nat Rev Microbiol; 2004 Dec; 2(12):984-9. PubMed ID: 15550944 [TBL] [Abstract][Full Text] [Related]
4. Building country capacity to sustain NTD programs and progress: A call to action. Sodahlon Y; Ross DA; McPhillips-Tangum C; Lawrence J; Taylor R; McFarland DA; Krentel A; Anyaikea C; Batcho WE; Bougouma C; Dantas APC; Dhingra N; Guambe MM; Ibrahim K; Kargbo-Labour IJ; Matwale GK; Momprevil FN; Monteiro MAA; Nko'Ayissi GB; Omondi WP; Randrianirina LH; Salissou BA; Schuler HR; Silva do Rosário AS; Sitima LD; Togbey KM; Victor B; Malecela MN PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008565. PubMed ID: 33031387 [No Abstract] [Full Text] [Related]
6. Supply of ivermectin in developing countries. Van Damme W Lancet; 1993 Mar; 341(8845):634-5. PubMed ID: 8094862 [No Abstract] [Full Text] [Related]
7. The path to new medicines. Callan B; Gillespie I Nature; 2007 Sep; 449(7159):164-5. PubMed ID: 17851511 [No Abstract] [Full Text] [Related]
8. Government action needed to step up research and development for world's most neglected diseases. Pecoul B Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495 [No Abstract] [Full Text] [Related]
9. Ivermectin in lymphatic filariasis. N Engl J Med; 1990 Sep; 323(13):917-8. PubMed ID: 2395445 [No Abstract] [Full Text] [Related]
10. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer. Witty A Health Aff (Millwood); 2009; 28(3):w411-6. PubMed ID: 19299425 [No Abstract] [Full Text] [Related]
12. Ivermectin and onchocerciasis: is it all solved? Hopkins AD Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585 [TBL] [Abstract][Full Text] [Related]
16. Executive summary: global antimicrobial resistance alerts and implications. Alliance for the Prudent Use of Antibiotics Clin Infect Dis; 2005 Aug; 41 Suppl 4():S221-3. PubMed ID: 16032555 [No Abstract] [Full Text] [Related]
17. Merck's new drug free to WHO for river blindness programme. Lindley D Nature; 1987 Oct 29-Nov 4; 329(6142):752. PubMed ID: 3670379 [No Abstract] [Full Text] [Related]
18. Editorial: drug development for neglected diseases: a public health challenge. Fehr A; Thürmann P; Razum O Trop Med Int Health; 2006 Sep; 11(9):1335-8. PubMed ID: 16930253 [No Abstract] [Full Text] [Related]
19. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Olsen A Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):747-58. PubMed ID: 17481681 [TBL] [Abstract][Full Text] [Related]
20. Singapore infectious diseases comes of age. Allen DM Singapore Med J; 1994 Jun; 35(3):314-5. PubMed ID: 7997913 [No Abstract] [Full Text] [Related] [Next] [New Search]